Continuous Glucose Monitor
Top in endocrinology: New OTC glucose monitors; exposure to endocrine-disrupting chemicals
The FDA recently cleared two over-the-counter continuous glucose monitoring systems, one for adults with type 2 diabetes who do not use insulin and another for adults without diabetes who are looking to improve overall health and wellness.
Top in endocrinology: Vitamin D guidance; menopausal hormone therapy benefits the brain
A daily vitamin D intake of 600 IU, as recommended by the National Academy of Medicine, is sufficient for most adults, and only a few groups may see benefits from higher levels, according to a presentation at ENDO 2024.
FDA clears OTC CGMs for general public, adults with type 2 diabetes who do not use insulin
The FDA granted clearance for two new over-the-counter continuous glucose monitoring systems, one for adults with type 2 diabetes who do not use insulin and another for adults without diabetes, according to an industry press release.
Direct to Apple Watch compatibility announced for Dexcom G7 CGM
A continuous glucose monitoring system has the capability to connect directly with the Apple Watch for people with diabetes, according to a press release from Dexcom.
Next step in diabetes care: Use CGM data to inform treatment decisions
BOSTON — Continuous glucose monitoring has transformed the field of diabetes over the past 25 years. The technology can be used by both providers and people with diabetes to improve disease management, according to a speaker at ENDO 2024.
Miniature-sized insulin pump now compatible with two CGM systems
A miniature-sized automated insulin delivery system cleared by the FDA in 2023 is now compatible with a new-generation continuous glucose monitor, according to a press release.
FDA OK’s first artificial pancreas for managing type 1 diabetes during pregnancy
The FDA authorized a closed-loop algorithm for an artificial pancreas system for use by people with type 1 diabetes aged 2 years and older, including during pregnancy, according to press release from Cambridge University.
Tirzepatide lowers body weight, improves glycemic control for adults with type 1 diabetes
Adults with type 1 diabetes and overweight or obesity prescribed tirzepatide off-label had a reduction in body weight and improvements in HbA1c and continuous glucose monitoring metrics, according to data from a real-world study.
Noninvasive radiofrequency sensor with machine learning may accurately measure glucose
NEW ORLEANS —A noninvasive device using a radiofrequency sensor may be able to measure glucose levels for people with diabetes in the future, according to a speaker at the AACE Annual Meeting.
Fully-implantable CGM receives FDA authorization for integration with insulin pumps
The FDA granted integrated continuous glucose monitoring designation to a fully-implantable CGM, according to a press release.